Elevated nonfasting C-peptide levels, a surrogate marker for pancreatic insulin secretion, were associated with a higher breast cancer risk among women above 60 years of age within the EPIC (European Prospective Investigation into Cancer and Nutrition) study [119]. The gene discussed is INS; the disease is breast carcinoma.